Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y
Fourth Department of Internal Medicine, University of Tokyo School of Medicine, Japan.
Biochem J. 1990 Feb 15;266(1):15-24. doi: 10.1042/bj2660015.
Proteoglycans in mineralized (0.5 M-EDTA/4 M-guanidinium chloride-extractable) and non-mineralized (4 M-guanidinium chloride-extractable) matrices synthesized by a mouse osteoblastic-cell line MC3T3-E1 were characterized at different phases of mineralization in vitro. Cell cultures were labelled with [35S]sulphate and either [3H]glucosamine or 3H-labelled amino acids. At the mineralization phase a large majority of proteoglycans were extracted with 4 M-guanidinium chloride (G extract), and at least five species of labelled proteoglycans were identified; dermatan sulphate proteoglycans (DSPG), apparent Mr approx. 120,000 and 70,000), heparan sulphate proteoglycans (HSPG, apparent Mr approx. 200,000 and 120,000) and DS chains with very little core protein. DSPGs weakly bound to an octyl-Sepharose CL-4B column and HSPGs bound more tightly, whereas DS chains did not bind to the column. Amounts of labelled proteoglycans extracted with 0.5 M-EDTA/4 M-guanidinium chloride (EDTA extract) were much less than those in G extract. Although the predominant species in the EDTA extract were comparable with the DS or DSPGs in the G extract, none of them bound to octyl-Sepharose CL-4B, indicating their lack of hydrophobicity. At the nonmineralizing phase a large chondroitin sulphate proteoglycan (Mr greater than 600,000) was found in the matrix in addition to the five proteoglycan species similar to those at the mineralization phase. Although DS chains at the early phase were similar in size to those at the mineralization phase, the ratio of 2-acetamido-2-deoxy-3-O-(beta-D-gluco-4-enepyranosyluronic acid)-4-O-sulpho-D-galactose to 2-acetamido-2-deoxy-3-O-(beta-D-gluculo-4-enepyranosyluronic acid)-6-O-sulpho-D-galactose was less than that at the mineralization phase. These results agree with those of previous studies performed in vivo and suggest that alteration in the synthesis of proteoglycans is involved in the mineralization process. They also suggest that at the osteoblastic mineralization front proteoglycans undergo partial degradation and lose their hydrophobicity.
通过小鼠成骨细胞系MC3T3-E1合成的矿化基质(0.5M-EDTA/4M-氯化胍可提取)和非矿化基质(4M-氯化胍可提取)中的蛋白聚糖,在体外矿化的不同阶段进行了表征。细胞培养物用[35S]硫酸盐和[3H]葡糖胺或3H标记的氨基酸进行标记。在矿化阶段,绝大多数蛋白聚糖用4M-氯化胍(G提取物)提取,并且鉴定出至少五种标记的蛋白聚糖;硫酸皮肤素蛋白聚糖(DSPG),表观分子量约为120,000和70,000)、硫酸乙酰肝素蛋白聚糖(HSPG,表观分子量约为200,000和120,000)以及核心蛋白极少的DS链。DSPG与辛基-Sepharose CL-4B柱弱结合,而HSPG结合更紧密,而DS链不与该柱结合。用0.5M-EDTA/4M-氯化胍(EDTA提取物)提取的标记蛋白聚糖的量远少于G提取物中的量。尽管EDTA提取物中的主要种类与G提取物中的DS或DSPG相当,但它们都不与辛基-Sepharose CL-4B结合,表明它们缺乏疏水性。在非矿化阶段,除了与矿化阶段相似的五种蛋白聚糖种类外,在基质中还发现了一种大的硫酸软骨素蛋白聚糖(分子量大于600,000)。尽管早期的DS链在大小上与矿化阶段的相似,但2-乙酰氨基-2-脱氧-3-O-(β-D-葡糖-4-烯吡喃糖醛酸)-4-O-磺基-D-半乳糖与